BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22528804)

  • 1. Prognostic significance of NANOG and KLF4 for breast cancer.
    Nagata T; Shimada Y; Sekine S; Hori R; Matsui K; Okumura T; Sawada S; Fukuoka J; Tsukada K
    Breast Cancer; 2014 Jan; 21(1):96-101. PubMed ID: 22528804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer.
    Nagata T; Shimada Y; Sekine S; Moriyama M; Hashimoto I; Matsui K; Okumura T; Hori T; Imura J; Tsukada K
    Breast Cancer; 2017 Mar; 24(2):326-335. PubMed ID: 27300169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
    Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
    J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray.
    Shimada Y; Okumura T; Sekine S; Moriyama M; Sawada S; Matsui K; Yoshioka I; Hojo S; Yoshida T; Nagata T; Fukuoka J; Tsukada K
    Anticancer Res; 2012 Dec; 32(12):5507-14. PubMed ID: 23225459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells.
    Saiki Y; Ishimaru S; Mimori K; Takatsuno Y; Nagahara M; Ishii H; Yamada K; Mori M
    Ann Surg Oncol; 2009 Sep; 16(9):2638-44. PubMed ID: 19554373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review.
    van Schaijik B; Davis PF; Wickremesekera AC; Tan ST; Itinteang T
    J Clin Pathol; 2018 Jan; 71(1):88-91. PubMed ID: 29180509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
    Liu L; Wu L; Wei X; Ling J
    Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.
    Elsir T; Edqvist PH; Carlson J; Ribom D; Bergqvist M; Ekman S; Popova SN; Alafuzoff I; Ponten F; Nistér M; Smits A
    Int J Cancer; 2014 Mar; 134(5):1123-31. PubMed ID: 24037901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
    Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
    J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cell-related Genes Correlate With Poor Prognoses of Oral Squamous Cell Carcinoma.
    Muraki Y; Hasegawa T; Takeda D; Ueha T; Iwata E; Saito I; Amano R; Sakakibara A; Akashi M; Komori T
    Anticancer Res; 2019 Mar; 39(3):1205-1216. PubMed ID: 30842151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
    Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
    Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
    Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
    Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.
    Liu Y; Zhang C; Fan J; Xiao L; Yin B; Zhou L; Xia S
    World J Surg Oncol; 2011 Oct; 9():121. PubMed ID: 21982273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
    Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
    Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant association of combination of OCT4, NANOG, and SOX2 gene polymorphisms in susceptibility and response to treatment in North Indian breast cancer patients.
    Tulsyan S; Agarwal G; Lal P; Mittal B
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1065-78. PubMed ID: 25223935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.